HR 5239
116th Congress
House
Health
Business records
Federal preemption
Government information and archives
Health care costs and insurance
Inflation and prices
Prescription drugs
Retail and wholesale trades
State and local government operations
Prescription Drug Price Reporting Act
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 22, 2019
Referred to the Subcommittee on Health.
Nov 21, 2019
Referred to the House Committee on Energy and Commerce.
Nov 21, 2019
Introduced in House
Plain-English summary
Prescription Drug Price Reporting Act
This bill requires that all prescription drug manufacturers submit certain information for every drug marketed in the United States to the Department of Health and Human Services (HHS). Specifically, manufacturers must provide information about cost, pricing, and rebates. Manufacturers are also required to submit any price changes to a prescription drug at least 30 days in advance.
HHS must make this information available through a public database that enables consumers to subscribe to price change notifications for different types of prescriptions drugs.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2